Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Nov 08, 2023

$CLLS, $EDIT, and $CRSP: Biotech Trio Skyrockets with a Remarkable +13.25% Weekly Surge

Robots for this industry :
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA) - 30-day Annualized Return +33%
Day Trader: High Volatility Stocks for Active Trading (TA&FA) - 30-day Annualized Return +16%

 

Biotechnology companies have been a hotspot in the stock market recently, showing remarkable performance with a notable 13.25% increase in the past week. This impressive upswing is mirrored by the positive outlook for several key tickers in this sector, including CLLS, EDIT, and CRSP. In this article, we will explore the recent developments in these biotechnology companies and highlight key indicators that suggest their continued growth.

Group of Tickers: CLLS, EDIT, CRSP

Positive Outlook with Volume Indicator Backing

The positive outlook for these biotechnology stocks is supported by the Volume Indicator, a metric that signifies strong investor interest and demand for these stocks. Tickeron, a renowned market analysis tool, is optimistic about this group and predicts a further increase of over 4.00% within the next month, with a 56% likelihood. Notably, the daily ratio of advancing to declining volumes within this group was 2.35 to 1, highlighting a strong buying sentiment among investors.

MA50MA10 Indicator Confirms Positive Trend

An important technical indicator, the MA50MA10, has confirmed the positive outlook for one of the tickers in this group. This indicator, with an average accuracy of 90%, suggests a favorable trend for this stock. It's a sign that these biotechnology companies have strong underlying market dynamics supporting their growth.

Market Capitalization Insights

The average market capitalization across this group of biotechnology stocks is approximately 1.6 billion USD. The market cap for individual tickers within the group varies, with CRSP holding the highest valuation at 4 billion USD, while CLLS is the lowest-valued company at 159.1 million USD. These varying market caps reflect the diversity within the biotechnology sector.

High and Low Price Movements

Recent price movements for these stocks have been quite dynamic. On average, these stocks exhibited a weekly price growth of 78.2%, a monthly growth of 41.87%, and a quarterly growth of 0.83%. Notably, CLLS saw the highest weekly price growth at 170.88%, while EDIT experienced the most significant decline at 31.28%.

Key Stock Movements

CRSP's Volatile Week: CRISPR Therapeutics AG (CRSP) experienced a rollercoaster week. On 11/3/23, the stock witnessed a substantial gain of 18.08%, positioning it as a top weekly gainer. However, on 8/3/23, just a day later, CRSP declined by -7.45%, marking it as a top loser for the week. These rapid fluctuations suggest the need for vigilant monitoring of CRSP.

CLLS's Sharp Downturn: Cellectis SA (CLLS) encountered a tough week on 8/3/23, as it emerged as a top weekly loser among penny stocks with a significant drop of -16.52%. Investors should closely analyze the reasons behind this decline and consider the long-term prospects for CLLS.

Volume Surge: Volume has played a crucial role in the recent movements of these stocks. The average weekly volume growth for the group was an astounding 1270.43%, and the monthly and quarterly volume growth were 1064.05% and 1045.67%, respectively. This surge in volume indicates heightened market activity and interest in biotechnology stocks.

Key Technical Indicators for Individual Stocks

  1. CLLS's Aroon Indicator: CLLS's Aroon Indicator entered a downward trend on October 31, 2023. This indicator suggests a potential strong downward move for the stock, with historical data indicating an 85% probability of a downward trend. Current price: $2.52. Support and resistance levels: $2.07 and $3.06, respectively. Recent trends show substantial uptrend growth during October and the week of 10/30/23 - 11/06/23.

  2. EDIT's MACD Histogram: The Moving Average Convergence Divergence (MACD) for EDIT turned positive on October 25, 2023, indicating a 79% probability of continued upward momentum. Current price: $8.52. Support and resistance levels: $8.21 and $11.68, respectively. Recent trends show uptrend growth during October and the week of 10/30/23 - 11/06/23.

  3. CRSP's RSI Oscillator: The RSI Oscillator for CRSP moved out of oversold territory on October 23, 2023, with a 90% probability of an upward move. Current price: $56.49. Resistance and support levels: $42.40 and $61.15, respectively. Recent trends show a downtrend during October and the week of 10/23/23 - 10/30/23.

In summary, the biotechnology sector, particularly represented by CLLS, EDIT, and CRSP, has recently demonstrated significant growth. Positive technical indicators, substantial volume increases, and notable price movements contribute to the overall optimism in this sector.

Related Ticker: CLLS, EDIT, CRSP

CLLS sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CLLS moved below the 200-day moving average on July 10, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on July 19, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CLLS as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLLS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CLLS entered a downward trend on July 09, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLLS's RSI Oscillator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CLLS just turned positive on July 03, 2024. Looking at past instances where CLLS's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLLS advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

Tickeron has a positive outlook on this ticker and predicts a further increase by more than 4.00% within the next month with a likelihood of 69%.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.244) is normal, around the industry mean (12.553). P/E Ratio (0.000) is within average values for comparable stocks, (157.728). CLLS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.453). Dividend Yield (0.000) settles around the average of (0.064) among similar stocks. P/S Ratio (27.624) is also within normal values, averaging (216.254).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Novavax (NASDAQ:NVAX), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.89B. The market cap for tickers in the group ranges from 151 to 579.21B. NONOF holds the highest valuation in this group at 579.21B. The lowest valued company is MYMX at 151.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -2%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 25%. SILO experienced the highest price growth at 144%, while ASLN experienced the biggest fall at -76%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -42% and the average quarterly volume growth was 56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 56
SMR Rating: 94
Profit Risk Rating: 93
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
CLLS
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a genome engineering company of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
8, rue de la Croix Jarry
Phone
+33 181691600
Employees
285
Web
https://www.cellectis.com
Ad is loading...
Discover the dynamic world of cryptocurrency trading with Tickeron's AI analysis. Capitalize on bullish and bearish patterns in Origin Protocol (OGN.X), with gains up to 27.80%. Stay ahead with Tickeron's real-time insights and make informed trading decisions. #CryptoTrading #AIAnalysis #OriginProtocol #InvestSmart
#latest#popular#patterns#artificial_intelligence#trading#technical_analysis
Dive into the world of trading excellence with our Best AI Robot of the week! In a market characterized by growth, the key to maximizing profits lies not only in mainstream large-cap stocks but also in exploring opportunities across different market segments.
This article delves into the performance of AI trading robots, specifically those utilizing the "Swing trader: Long-Short Equity Strategy (TA&FA)." These bots showcased their prowess by delivering a notable +4.98% gain while engaging in MRNA trades over the previous week. Beyond mere statistics, we explore the technical indicators and recent earnings report of MRNA to shed light on the underlying dynamics influencing the stock.
Artificial intelligence (AI) trading bots have become powerful tools for investors seeking active trading opportunities. In a recent analysis conducted on the "Day Trader: High Volatility Stocks for Active Trading (TA&FA)" platform, AI trading bots exhibited impressive performance, generating a noteworthy +4.81% gain while actively trading Shopify (SHOP) over the course of the previous week.
In the dynamic world of finance, strategic asset acquisition is a game-changer. Recently, a group of stocks within this domain has been in the spotlight, showcasing notable performances and intriguing patterns. This article delves into the recent movements of these stocks, focusing on key indicators, market capitalization, notable price events, and volume dynamics.
The Tickeron quant team is delighted to introduce our best robot of the week tailored for Trend Traders. Our sophisticated AI Robot, has been designed for manual trading enthusiasts who value independent signal selection.
Tickeron's Quant team is delighted to introduce our latest AI-powered robot designed for trading small-cap stocks, employing a distinctive fundamental stock analysis algorithm. This algorithm, renowned for its blend of in-depth analysis and intuitive signal-following capabilities, is well-suited for both novice and seasoned traders.
The Tickeron quant team proudly presents our top-performing AI robot for swing traders. This robot stands out with its remarkable accuracy, empowering traders to capitalize on diverse market conditions and transaction types. Demonstrating its proficiency, it achieved profitability in short trades during last week's strong uptrend in the US stock markets.
One such example is the "Trend Trader: Popular Stocks (TA&FA)" platform, where AI trading robots demonstrated their prowess by generating a notable gain while actively trading Adobe Inc. (ADBE) over the previous week. In this article, we delve into a technical analysis of ADBE's recent performance, shedding light on key indicators and recent earnings results.
​​​​​​​The railroads sector, encompassing prominent players such as Canadian Pacific Railway (CP), CSX Corporation (CSX), Norfolk Southern Corporation (NSC), Canadian National Railway Company (CNI), and Union Pacific Corporation (UNP), has undergone a noteworthy surge in performance over the past week. However, a closer examination reveals a complex landscape marked by negative outlook signals and fluctuating market dynamics.
The Tickeron quant team is excited to introduce our premier AI robot, specifically optimized for Swing Traders. This tool represents the pinnacle of our technological advancements in trading algorithms. Excelling in the market, it has achieved an impressive feat, earning twice as much as the S&P 500 in just the past week.
In the whirlwind of the current mergers and acquisitions frenzy, investors are reaping substantial rewards as stocks within the merger industry theme surged by an impressive 20.9% on average over the past month.
The Tickeron quant team is delighted to introduce our top-performing AI robot tailored for beginners. Our AI Robot specializes in navigating the high-tech stocks within the NASDAQ 100 index, renowned for their liquidity and moderate volatility—making them an ideal choice for novice traders.
In the dynamic landscape of the US stock markets, where unpredictability has become the norm, finding a trading strategy that not only thrives in periods of growth but also shields against sharp corrections is paramount.
The Tickeron quant team proudly introduces our premier AI Robot, tailor-made for trend traders who prefer manual trading and selecting their own signals. This AI Robot stands out with its impressive track record of consistent trading predictions, empowering traders to align their decisions with personal preferences.
Tickeron is excited to highlight the exceptional performance of our top AI robot this week, given the recent downturn in major US stock indices. While the SP500, NASDAQ 100, and Dow Jones Industrial all experienced declines, our AI robot, thanks to its well-calibrated diversification across various industries, demonstrated remarkable resilience.
As the trading week came to a close on Friday, there were notable movements across various asset classes:
Tickeron's quant team diligently monitors developed trading algorithms daily to determine the most effective ones. Today, we are delighted to present three of the best robots tailored for swing traders, showcasing consistently positive results over several months, irrespective of market conditions. This week, they underscored their efficacy by yielding impressive gains across various stocks, even as major US stock indexes dipped.
Tickeron is excited to highlight the exceptional performance of our top AI robot this week. The US stock market has experienced a consistent upward trend for the past five months, heightening the anticipation of a forthcoming correction with each passing day.
Introducing our top-performing best AI Robot of the week, designed by Tickeron's expert quant team for trading small-cap stocks. This algorithm blends classical and proprietary technical indicators, honed through advanced machine learning, to empower users with effective portfolio diversification and maximum profitability in the dynamic market.